MDT

86.79

+0.46%↑

A

113.49

-1.49%↓

VEEV

171.56

-1.05%↓

HQY

81.28

-2.94%↓

PHR.US

9.16

+2.69%↑

MDT

86.79

+0.46%↑

A

113.49

-1.49%↓

VEEV

171.56

-1.05%↓

HQY

81.28

-2.94%↓

PHR.US

9.16

+2.69%↑

MDT

86.79

+0.46%↑

A

113.49

-1.49%↓

VEEV

171.56

-1.05%↓

HQY

81.28

-2.94%↓

PHR.US

9.16

+2.69%↑

MDT

86.79

+0.46%↑

A

113.49

-1.49%↓

VEEV

171.56

-1.05%↓

HQY

81.28

-2.94%↓

PHR.US

9.16

+2.69%↑

MDT

86.79

+0.46%↑

A

113.49

-1.49%↓

VEEV

171.56

-1.05%↓

HQY

81.28

-2.94%↓

PHR.US

9.16

+2.69%↑

Search

Palvella Therapeutics Inc

Open

SectorHealthcare

117.57 -3.42

Overview

Share price change

24h

Current

Min

111.86

Max

121.28

Key metrics

By Trading Economics

Income

-1.9M

-11M

Employees

14

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+93.98% upside

Dividends

By Dow Jones

Next Earnings

14 May 2026

Market Stats

By TradingEconomics

Market Cap

1.4B

Previous open

120.99

Previous close

117.57

News Sentiment

By Acuity

50%

50%

170 / 349 Healthcare

Palvella Therapeutics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

6 Apr 2026, 23:17 UTC

Earnings

Samsung Forecasts Record First-Quarter Operating Profit

6 Apr 2026, 23:00 UTC

Hot Stocks

Stocks to Watch: Health Insurers, Mawson, Owlet

6 Apr 2026, 22:13 UTC

Major Market Movers

Health Insurance Shares Gain on 2.48% Medicare Rate Bump

6 Apr 2026, 21:46 UTC

Acquisitions, Mergers, Takeovers

BP 'Optimizes Portfolio' and Sells 13 Thorntons Stores to Giant Oil -- OPIS

6 Apr 2026, 17:09 UTC

Major Market Movers

Viridian Shares Fall After Competing Amgen Eye Drug Performs Well

6 Apr 2026, 16:56 UTC

Major News Events

U.S. Released 1.5 Million Bbls of Crude From SPR Last Week, DOE Data Show -- OPIS

6 Apr 2026, 14:47 UTC

Major Market Movers

Stereotaxis Shares Rise on FDA Clearance for Synchrony

7 Apr 2026, 00:00 UTC

Major News Events

Ukraine's Lesson for Trump: Military Dominance Opens Waterways -- WSJ

6 Apr 2026, 23:58 UTC

Market Talk
Major News Events

Iran War Will Keep Oil Prices High Through 2Q, Says Westpac -- Market Talk

6 Apr 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for Iran Cease-Fire -- Market Talk

6 Apr 2026, 23:36 UTC

Market Talk

Gold Edges Higher as Investors Focus on U.S.-Iran Conflict -- Market Talk

6 Apr 2026, 23:15 UTC

Market Talk

RBA Won't Raise Rates as Australia's Economy Softens Fast -- Market Talk

6 Apr 2026, 22:52 UTC

Market Talk

Global Equities Roundup: Market Talk

6 Apr 2026, 22:52 UTC

Market Talk

Pro Medicus Unlikely to Complete New Buyback in Full -- Market Talk

6 Apr 2026, 22:14 UTC

Market Talk

Correction to Live Cattle Futures Article

6 Apr 2026, 20:56 UTC

Market Talk

Mexican Private Consumption Fell in January -- Market Talk

6 Apr 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

6 Apr 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

6 Apr 2026, 19:58 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

6 Apr 2026, 19:58 UTC

Market Talk

Live Cattle Futures Hit Record High, Hogs Edge Up -- Market Talk

6 Apr 2026, 19:11 UTC

Market Talk

U.S. Natural Gas Edges Up in Rangebound Trade -- Market Talk

6 Apr 2026, 19:06 UTC

Market Talk

Treasury Yields Decline as a Belligerent Trump Talks to Reporters -- Market Talk

6 Apr 2026, 19:03 UTC

Market Talk

Global Energy Roundup: Market Talk

6 Apr 2026, 19:03 UTC

Market Talk

Crude Futures Edge Up As Trump's Iran Deadline Nears -- Market Talk

6 Apr 2026, 18:36 UTC

Acquisitions, Mergers, Takeovers

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6 Apr 2026, 17:59 UTC

Market Talk
Major News Events

Travel Booking Companies Facing More Demand Uncertainty Than Expected -- Market Talk

6 Apr 2026, 17:13 UTC

Acquisitions, Mergers, Takeovers

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6 Apr 2026, 16:33 UTC

Market Talk

Oil Futures Steady as Market Awaits Trump -- Market Talk

6 Apr 2026, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

6 Apr 2026, 14:59 UTC

Earnings

Strategy Records a $14.5 Billion Unrealized Loss in First Quarter -- WSJ

Peer Comparison

Price change

Palvella Therapeutics Inc Forecast

Price Target

By TipRanks

93.98% upside

12 Months Forecast

Average 232.5 USD  93.98%

High 270 USD

Low 209 USD

Based on 13 Wall Street analysts offering 12 month price targets forPalvella Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

13 ratings

13

Buy

0

Hold

0

Sell

Sentiment

By Acuity

170 / 349 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Pre-tax profit

Sales

Interest expense on debt

Operating profit

$

help-icon Live chat